Evaluering av sikkerhet og effekt for Ebola vaksine i et distrikt i Guinea

Vitenskapelig tittel:

Evaluation of Ebola vaccine safety and efficacy in a Prefecture of Guinea. 

The current outbreak of Ebola Virus Disease (EVD) in West Africa is by far the largest outbreak ever recorded. The WHO meeting in sept-14 has proposed to fast-track clinical Ebola vaccine trials. This study has the potential to contribute to control the Ebola epidemic in West Africa and possibly prevent new, future outbreaks. The study aims to evaluate Ebola vaccine efficacy and the use of ring vaccination as a vaccine delivery strategy in a population in West Africa. In addition, it will offer vaccination to frontline workers. The study will also give more information on safety and immunogenicity of the vaccine, and possibly contribute to the establishment of a correlate of protection. The planned research will strengthen the capacity of conducting high quality research in Guinea through an international collaboration and engagement of the local community and authorities of Guinea. Furthermore, the study may help to design implementation strategy of Ebola vaccines in West Africa.
(Prosjektleders prosjektbeskrivelse)

Ref. nr.: 2014/2347 EudraCT-nummer: EudraCT number not applicable in Guinea. Will adhere to Guinean guidelines, GCP, and WHO/AVAREF regulations. Prosjektstart: 15.12.2014 Prosjektslutt: 30.06.2017

Behandlingsstatus: Pågående
Prosjektleder: John-Arne Røttingen
Initiativtaker: Bidragsforskning

There will be co-financing of the project. Currently, the project has received funding for 3 million USD from the Norwegian Research Council. 

Forskningsdata: Legemiddelutprøving, Registerdata, Humant biologisk materiale, Mennesker
Utvalg: Andre personer i en sårbar eller avhengig situasjon

Behandlet i REK
15.01.2015 REK sør-øst
07.05.2015 REK sør-øst
20.08.2015 REK sør-øst
20.08.2015 REK sør-øst
17.09.2015 REK sør-øst
17.09.2015 REK sør-øst
29.10.2015 REK sør-øst